SCHEMBL19939367

SCHEMBL19939367

N#Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5cc(-c6ccccc6)nc(-c6ccccc6)n5)cc4)c4ccccc34)cc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 9/20 0.57
GABRA1 P14867 1/20 0.51
GABRG2 P18507 1/20 0.51
GABRB3 P28472 1/20 0.51
GABRA5 P31644 1/20 0.51
GABRA3 P34903 1/20 0.51
ABCB1 P08183 5/20 0.51
MYC P01106 1/20 0.51
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
NTSR1 P30989 1/20 0.49
ALDH1A1 P00352 1/20 0.49
MAPT P10636 1/20 0.49
HPGD P15428 1/20 0.49
ALDH1A3 P47895 1/20 0.48
SQOR Q9Y6N5 2/20 0.48
KDM4E B2RXH2 1/20 0.47
LMNA P02545 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
ADORA2A P29274 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22115123 1.00 ABCG2 (0.57) ABCG2GABRA1GABRG2GABRB3GABRA5
SCHEMBL19939375 1.00 ABCG2 (0.57) ABCG2GABRA1GABRG2GABRB3GABRA5
SCHEMBL19939376 0.98 ABCG2 (0.58) ABCG2GABRA1GABRG2GABRB3GABRA5
SCHEMBL19939368 0.98 ABCG2 (0.58) ABCG2GABRA1GABRG2GABRB3GABRA5
SCHEMBL22987059 0.95 ABCG2 (0.52) ABCG2GABRA1GABRG2GABRB3GABRA5
SCHEMBL18010668 0.94 ABCG2 (0.57) ABCG2GABRA1GABRG2GABRB3GABRA5
SCHEMBL17969955 0.94 ABCG2 (0.57) ABCG2GABRA1GABRG2GABRB3GABRA5
SCHEMBL23873876 0.93 CYP1A2 (0.51) ABCG2GABRA1GABRG2GABRB3GABRA5
SCHEMBL22987056 0.93 ABCG2 (0.50) ABCG2GABRA1GABRG2GABRB3GABRA5
SCHEMBL22987175 0.93 ABCG2 (0.53) ABCG2GABRA1GABRG2GABRB3GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210305516-A1 ORGANIC LIGHT-EMITTING DEVICE LG CHEM, LTD. (KR) 2021-09-30 US disclosed
US-20210050528-A1 ORGANIC LIGHT EMITTING DIODE LG CHEM, LTD. (KR) 2021-02-18 US disclosed
US-20180066180-A1 ORGANIC LIGHT-EMITTING DEVICE LG CHEM, LTD. (KR) 2018-03-08 US disclosed
US-20180066180-A1 ORGANIC LIGHT-EMITTING DEVICE LG CHEM, LTD. (KR) 2018-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210305516-A1 ORGANIC LIGHT-EMITTING DEVICE AOC2, RUVBL2, RUVBL1 ABCG2 3953/4885GABRA1 2575/4885GABRG2 3124/4885
US-20180066180-A1 ORGANIC LIGHT-EMITTING DEVICE CRY1, CRY2, PPOX ABCG2 3620/4885GABRA1 1046/4885GABRG2 914/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.